March 2008 Vol. 23 No. 3

by Kirsten Goldberg — last modified 2008-05-13 14:23

Drug Companies Agree To Pay $125 Million To Settle Litigation Over Drug Pricing. Phase III Trial Stopped After Novartis Drug Provides Better PFS In Kidney Cancer. FDA Grants Orphan Status To ActivBiotics Small Molecule.

Welcome. Please log in to download the newsletter if you are a subscriber. You can use the log in box in the right column. If not a subscriber, please subscribe or get a one day pass using the links below.

Click here to subscribe

Click here to get a one day pass

Log in: Login Name

Password

Cookies are not enabled. You must enable cookies before you can log in.; Forgot your password?

Google Ad Links

Google Ads

This site conforms to the following standards:

Section 508
WCAG
Valid XHTML
Valid CSS
Usable in any browser

The Cancer Letter

Sections

Personal tools

Document Actions

March 2008 Vol. 23 No. 3